Thursday, September 17, 2020

Azithromycin, potential COVID-19 drug, may increase risk for cardiac events

Azithromycin`s association with cardiac events also has been debated. In 2012, the FDA issued a warning for azithromycin stating that it had been linked to cardiac events, but subsequent studies have yielded mixed results.

from Zee News :Zee News - Health https://ift.tt/3c7HT5P
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

India reports first known case of MYSM1-related bone marrow failure syndrome in child

Doctors have treated what is believed to be India’s first known case of MYSM1-related bone marrow failure syndrome, a very rare inherited d...